4.8 Article

Simple Microfluidic Approach to Fabricate Monodisperse Hollow Microparticles for Multidrug Delivery

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 7, Issue 27, Pages 14822-14832

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.5b04824

Keywords

hollow microparticles; PDMS microfluidics; solvent diffusion; drug delivery; multidrug encapsulation

Funding

  1. European Union [VP1-3.1-SMM-01]
  2. Academy of Finland [252215, 281300, 251629]
  3. University of Helsinki Research Funds
  4. Biocentrum Helsinki
  5. European Research Council [310892, 311705]
  6. Jane and Aatos Erkko Foundation [4704010]
  7. Lithuanian Agency for Science, Innovation and Technology (MITA) [uVesicles 31v-40]
  8. European Research Council (ERC) [311705] Funding Source: European Research Council (ERC)
  9. Academy of Finland (AKA) [251629, 251629] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

Herein, we report the production of monodisperse hollow microparticles from three different, polymers, namely, pH-reponsive acetylated dextran and hypromellose acetate succinate and biodegradable poly(lactic-co-glycolic acid), at varying polymer concentrations using a poly(dimethylsiloxane)-based microfluidic,device, Hollow microparticles formed during solvent diffusion into the continuous phase when the polymer dose to the interface solidified, forming the shell. in the inner part of the particle, phase separation induced solvent droplet formation, which dissolved the shell, forming a hole and a hollow-core particle. Computational simulations showed that, despite the presence of convective recirculation around the droplet, the mass-transfer rate of the solvent dissolution from the droplet to the surrounding phase was dominated by diffusion. To illustrate the potential use of hollow microparticles, we simultaneously encapsulated two anticancer drugs and investigated their loading and release profiles. In addition, by utilizing different polymer shells and polymer concentrations, the release profiles of the model drugs could be tailored according to specific demands and applications. The high encapsulation efficiency, controlled drug release, unique hollow microparticle structure, small particle size (<7 mu m); and flexibility of the polymer choice could make these microparticles advanced platforms for pulmonary drug delivery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available